Photoaffinity labeling of subtype 2 angiotensin receptor of human myometrium

G Servant, G Boulay, R Bosse, E Escher and G Guillemette

Department of Pharmacology, Faculty of Medicine, University of Sherbrooke, Quebec, Canada.

Angiotensin II (AII) binding sites were characterized in human myometrium membrane preparations. The sites were saturable and of high affinity (Kd of 0.09 nM and Bmax of about 200 fmol/mg of protein). PD 123319 completely inhibited 125I-AII binding, with an IC50 of 30 nM, whereas L-158,809 (1 microM) had no significant effect on 125I-AII binding. These results indicate that human myometrium contains almost exclusively the AT2 receptor subtype. Association and dissociation studies performed with 125I-AII on human myometrium membranes revealed that AII had a very high affinity for AT2 receptors, with a Kd of 0.01 nM (association rate constant K1 = 1.056 x 10(12) mol-1 min-1; dissociation rate constant K2 = 0.003 min-1). The photoactivable AII analogue [Sar1, Val5, D-Phe8(N3)]AII displayed a high affinity for AT2 receptors (IC50 of 0.18 nM), but its radioiodinated form showed poor efficiency in photoaffinity labeling experiments. A newly synthesized photoactivatable analogue of AII, [Sar1, p-benzoyl-Phe8]AII, (AII-Bpa), also displayed a high affinity for AT2 receptors of human myometrium (IC50 of 0.3 nM). Photoaffinity labeling experiments were performed with 125I-AII-Bpa, and a high yield (70%) of covalent incorporation to human myometrium membranes was obtained upon photolysis. Covalently labeled receptors were solubilized, denatured, and subjected to polyacrylamide gel electrophoresis. Autoradiography of the polyacrylamide gel revealed a single band, of 68 kDa, and the labeling of this band was completely abolished in the presence of 1 microM PD 123319, indicating selective labeling of the AT2 receptor subtype. These results demonstrate that AII-Bpa is a very efficient tool for selective photoaffinity labeling of the AT2 receptor.

Volume 43, Issue 5, pp. 677-683, 05/01/1993
Copyright © 1993 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				J. L. Hansen, G. Servant, T. J. Baranski, T. Fujita, T. Iiri, and S. P. Sheikh Functional Reconstitution of the Angiotensin II Type 2 Receptor and Gi Activation Circ. Res., October 27, 2000; 87(9): 753 - 759. [Abstract] [Full Text] [PDF]

				M. Dong, Y. Wang, D. I. Pinon, E. M. Hadac, and L. J. Miller Demonstration of a Direct Interaction between Residue 22 in the Carboxyl-terminal Half of Secretin and the Amino-terminal Tail of the Secretin Receptor Using Photoaffinity Labeling J. Biol. Chem., January 8, 1999; 274(2): 903 - 909. [Abstract] [Full Text] [PDF]

				E. M. Hadac, D. I. Pinon, Z. Ji, E. L. Holicky, R. M. Henne, T. P. Lybrand, and L. J. Miller Direct Identification of a Second Distinct Site of Contact between Cholecystokinin and Its Receptor J. Biol. Chem., May 22, 1998; 273(21): 12988 - 12993. [Abstract] [Full Text] [PDF]

				G. Servant, S. A. Laporte, R. Leduc, E. Escher, and G. Guillemette Identification of Angiotensin II-binding Domains in the Rat AT2 Receptor with Photolabile Angiotensin Analogs J. Biol. Chem., March 28, 1997; 272(13): 8653 - 8659. [Abstract] [Full Text] [PDF]